Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram

被引:9
|
作者
Shi, Shuguang [1 ]
Miao, Zhongchang [1 ]
Zhou, Ying [1 ]
Xu, Chunling [1 ]
Zhang, Xue [1 ]
机构
[1] Nanjing Med Univ, Dept Radiol, Kangda Coll, Affiliated Hosp 1,Peoples Hosp Lianyungang 1, Jiangsu, Peoples R China
来源
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY | 2022年 / 28卷 / 05期
关键词
LYMPH-NODE; PHENOTYPE; PROGNOSIS;
D O I
10.5152/dir.2022.211034
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE Radiomics can be used to determine the prognosis of gastric cancer (GC). The objective of this study was to predict the disease-free survival (DFS) after GC surgery based on computed tomography-enhanced images combined with clinical features. METHODS Clinical, imaging, and pathological data of patients who underwent gastric adenocarcinoma resection from June 2015 to May 2019 were retrospectively analyzed. The primary outcome was DFS. Radiomics features were selected using Least Absolute Shrinkage and Selection Operator algorithm and converted into the Rad-score. A nomogram was constructed based on the Radscore and other clinical factors. The Rad-score and nomogram were validated in the training and validation groups. RESULTS Totally, 179 patients were randomly divided into the training (n = 124) and validation (n = 55) groups. In the training group, validation group, and overall population, the Rad-score could be divided into categories indicating low, moderate, and high risk of recurrence, metastasis, or death; all risk categories showed a significant difference between the training, validation, and overall population groups (all P <.001). Positive lymph nodes (hazard ratio (HR) = 3.07, 95% CI: 1.52-6.23, P =.002), cancer antigen-125 (HR = 3.24, 95% CI: 1.54-6.80, P =.002), and the Radscore (HR = 0.73, 95% CI: 0.61-0.87, P <.001) were independently associated with DFS. These 3 variables were used to construct a nomogram. In the training group, the areas under the curve at 3 years were 0.758 and 0.776 for the Rad-score and the nomogram, respectively, while they were both 1.000 in the validation group. The net benefit rate was analyzed using a decision curve in the training and validation groups, and the nomogram was superior to the single Rad-score. CONCLUSION Rad-score is an independent factor for DFS after gastrectomy for GC. The nomogram established in this study could be an effective tool for the clinical prediction of DFS after gastrectomy.
引用
收藏
页码:441 / +
页数:10
相关论文
共 50 条
  • [21] The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database
    Shuangxi Li
    Jacopo Desiderio
    Ziyu Li
    Federico Tozzi
    Jiafu Ji
    Amilcare Parisi
    International Journal of Clinical Oncology, 2021, 26 : 867 - 874
  • [22] Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer
    Ren, Jun
    Feng, Juan
    Song, Wei
    Wang, Chuntao
    Ge, Yuhang
    Fu, Tao
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (04) : 535 - 544
  • [23] Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer
    Jun Ren
    Juan Feng
    Wei Song
    Chuntao Wang
    Yuhang Ge
    Tao Fu
    Clinical and Experimental Medicine, 2020, 20 : 535 - 544
  • [24] Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
    Yuan, Chen
    Hu, Zhigang
    Wang, Kai
    Zou, Shubing
    FRONTIERS IN SURGERY, 2021, 8
  • [25] A 18F-FDG PET/CT based radiomics nomogram for predicting disease-free survival in stage II/III colorectal adenocarcinoma
    Wang, Bing
    Hu, Tianyuan
    Shen, Rongfang
    Liu, Lian
    Qiao, Junwei
    Zhang, Rongqin
    Zhang, Zhanwen
    ABDOMINAL RADIOLOGY, 2025, 50 (01) : 64 - 77
  • [26] Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma
    Zhao, Jin-du
    Lu, Xian-ying
    Chen, Tian -ping
    Duan, Xian-Lun
    Zuo, Wei
    Sai, Kai
    Zhu, Li -ran
    Gao, Qun
    EJSO, 2024, 50 (06):
  • [27] Development and Validation of a Nomogram for Predicting Survival Based on Ferritin and Transferrin Ratio in Breast Cancer Patients
    Huang, Shuqing
    Lai, Hao
    Pan, Xiaolan
    Lin, Qiumei
    Qin, Yuling
    Liu, Fengfei
    Fang, Min
    Huang, Wencheng
    Wei, Caibiao
    CANCER CONTROL, 2024, 31
  • [28] Development and validation of a nomogram for predicting overall survival in patients with early-onset endometrial cancer
    Zhang, Meng
    Li, Ruiping
    Zhang, Jiaxi
    Wang, Yunyun
    Wang, Yunlu
    Guo, Yuzhen
    BMC CANCER, 2023, 23 (01)
  • [29] Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients
    Zhu, Minggu
    Wang, Qicai
    Luo, Zhaowen
    Liu, Kelong
    Zhang, Zhiqiao
    ONCOTARGETS AND THERAPY, 2018, 11 : 8711 - 8722
  • [30] MRI radiomics for predicting poor disease-free survival in muscle invasive bladder cancer: the results of the retrospective cohort study
    Zhi-chang Fan
    Lu Zhang
    Guo-qiang Yang
    Shuo Li
    Jun-ting Guo
    Jing-jing Bai
    Bin Wang
    Yan Li
    Le Wang
    Xiao-chun Wang
    Abdominal Radiology, 2024, 49 : 151 - 162